top of page

Wed, Mar 31

|

Zoom

Clinical Experiences with Detox and IV NAD

Join Dr. Richard Mestayer, III for an exploration of his experiences using NAD IV for addiction. Dr. Mestayer serves as President and Medical Director of NAD Research, Inc. and runs a training program for medical practitioners who seek certification in BR+/NAD methods and protocols.

Registration is Closed
See other events
Clinical Experiences with Detox and IV NAD
Clinical Experiences with Detox and IV NAD

Time & Location

Mar 31, 2021, 11:00 AM

Zoom

Guests

About the Event

In his 39-year career as a practicing physician, Dr. Mestayer has helped countless men and women overcome chemical dependencies, traumatic stress, depression, anxiety, panic, and affective personality disorders. For 27 years he directed the behavioral medicine and stress treatment units at Ochsner Foundation Hospital, taught courses in psychosomatic medicine and personality disorders to residents accepted into Ochsner’s Psychiatric Residency program, where he was named “Teacher of the Year” in 1996. Other awards include “Best Doctor in New Orleans” by New Orleans magazine and the Ochsner Department of Psychiatry’s “Outstanding and Dedicated Service Award” in 2005.

Since his retirement in 2005 he has focused his efforts on addiction recovery and in 2008 as Chief Psychiatric Consultant at Springfield Wellness Center, a non-residential mental health clinic pioneering a proprietary formula of NAD (nicotine adenine dinucleotide) for the treatment of alcoholism, addiction, chronic and post-traumatic stress, depression, anxiety, and sleep disorders. Since February 2012 he has also served as President and Medical Director of NAD Research, Inc. and, since April 2014, as the sole proprietor of BR+ M.D. Consultants, LLC., a training program for medical practitioners who seek certification in BR+NAD methods and protocols, the pioneering work of Paula and Richard Mestayer. He is currently working with NAD Research, Inc. investigating new data regarding the efficacy of BR+NAD with addictions (alcohol and opiate) and Alzheimer’s and other neurodegenerative diseases.

Share This Event

bottom of page